NO970292L - Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener - Google Patents

Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener

Info

Publication number
NO970292L
NO970292L NO970292A NO970292A NO970292L NO 970292 L NO970292 L NO 970292L NO 970292 A NO970292 A NO 970292A NO 970292 A NO970292 A NO 970292A NO 970292 L NO970292 L NO 970292L
Authority
NO
Norway
Prior art keywords
solid phase
antibody
determination
antigens
multiple antigens
Prior art date
Application number
NO970292A
Other languages
English (en)
Other versions
NO970292D0 (no
Inventor
Ursula-Henrike Wienhues
Cornelia Kruse-Mueller
Eva Hoess
Elke Faatz
Beatus Ofenloch-Haehnle
Christoph Seidel
Michael Wiedmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430972A external-priority patent/DE4430972A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO970292D0 publication Critical patent/NO970292D0/no
Publication of NO970292L publication Critical patent/NO970292L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
NO970292A 1994-07-25 1997-01-23 Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener NO970292L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430972A DE4430972A1 (de) 1994-07-25 1994-08-31 Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene
PCT/EP1995/002919 WO1996003652A1 (de) 1994-07-25 1995-07-24 Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene

Publications (2)

Publication Number Publication Date
NO970292D0 NO970292D0 (no) 1997-01-23
NO970292L true NO970292L (no) 1997-03-13

Family

ID=25938668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970292A NO970292L (no) 1994-07-25 1997-01-23 Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener

Country Status (13)

Country Link
US (3) US6613530B1 (no)
EP (1) EP0772774B1 (no)
JP (1) JP3556228B2 (no)
CN (1) CN1148578C (no)
AT (1) ATE331952T1 (no)
AU (1) AU688953B2 (no)
CA (1) CA2195753C (no)
DE (1) DE59511054D1 (no)
ES (1) ES2268694T3 (no)
FI (1) FI970301A7 (no)
NO (1) NO970292L (no)
NZ (1) NZ291153A (no)
WO (1) WO1996003652A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ291153A (en) * 1994-07-25 1999-01-28 Boehringer Mannheim Gmbh Determination of a specific antibody using multiple antigens containing several epitope regions which react with the antibody
DE19649389A1 (de) 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgM-Nachweis
ES2187947T5 (es) 1997-03-10 2014-01-29 Roche Diagnostics Gmbh Procedimiento para la detección simultánea de antígenos de HIV y anticuerpos de HIV
ATE225511T1 (de) * 1997-12-11 2002-10-15 Roche Diagnostics Gmbh Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
DE10048417A1 (de) * 2000-09-29 2002-04-11 Roche Diagnostics Gmbh Verbindungen mit verzweigtem Linker
US7897404B2 (en) 2000-09-29 2011-03-01 Roche Diagnostics Operations, Inc. Conjugates of defined stoichiometry
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
JP2005508838A (ja) 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
EP1419386B1 (de) 2001-08-10 2006-07-12 Roche Diagnostics GmbH Verfahren zur herstellung von protein-beladenen mikropartikeln
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
US7851209B2 (en) * 2003-04-03 2010-12-14 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in assay devices
US7201903B2 (en) * 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005062053A2 (en) * 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005080939A2 (en) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2576902C (en) * 2004-06-30 2012-05-08 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (en) * 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1794586B1 (en) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoclonal antibodies to progastrin
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
EP1978365B1 (en) 2007-03-16 2010-08-25 Sysmex Corporation Reagent kit and method for measuring HCV antibody
ATE516298T1 (de) * 2007-04-20 2011-07-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
ES2421719T3 (es) * 2008-04-21 2013-09-05 Bio Rad Laboratories Antígeno de gliadina recombinante desamidada
EP2389585A2 (en) * 2009-01-22 2011-11-30 Li-Cor, Inc. Single molecule proteomics with dynamic probes
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2553452B1 (en) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Detection of feline immunodeficiency virus
TW201217783A (en) 2010-09-15 2012-05-01 Mbio Diagnostics Inc System and method for detecting multiple molecules in one assay
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2688268T3 (es) 2011-12-05 2018-10-31 Bio-Rad Laboratories, Inc. Antígeno de gliadina desamidada recombinante
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2018191645A1 (en) * 2017-04-14 2018-10-18 The Regents Of The University Of California Methods and devices for performing autoantibody assays
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
KR102772810B1 (ko) 2017-06-15 2025-02-28 캔서 어드밴시스 아이엔씨 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
CN108982832A (zh) * 2018-09-28 2018-12-11 蓝怡科技集团股份有限公司 一种免疫诊断用检测装置
CN110456073B (zh) * 2019-08-21 2023-09-22 广东菲鹏生物有限公司 双抗原夹心检测抗体的方法及试剂盒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837167A (en) * 1981-01-30 1989-06-06 Centocor, Inc. Immunoassay for multi-determinant antigens using high-affinity
GR850899B (no) * 1984-04-12 1985-11-25 Gen Hospital Corp
DK365785A (da) * 1984-09-17 1986-03-18 Hoffmann La Roche Metalcomplexer
ATE80740T1 (de) * 1987-06-09 1992-10-15 Cambridge Life Sciences Immunassay-verfahren.
AU1732988A (en) 1987-08-20 1989-02-23 Mooney Chemicals, Inc. High-solids coating compositions
IE63455B1 (en) * 1987-09-04 1995-04-19 Int Murex Tech Corp Immunoassay and biological constructs for use therein
NO884368L (no) * 1987-10-02 1989-04-03 Du Pont Immunanalyse ved anvendelse av igg-innfangelsesantistoff og multippel, monoklonalt antistoffpaavisningssystem.
EP0339695A3 (en) * 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
EP0449955B1 (en) * 1988-12-20 1996-03-06 Clarity Technologies Incorporated Synthetic hiv-like peptides, their compositions and uses
JPH02290554A (ja) 1989-02-09 1990-11-30 Meidensha Corp 酵素免疫測定試薬およびその調製方法
CA1340530C (en) 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
ATE167302T1 (de) * 1989-08-04 1998-06-15 Behringwerke Ag Heterogene bindungstests
JPH0389165A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH0389163A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH0389164A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH05133952A (ja) * 1991-04-03 1993-05-28 Syntex Usa Inc イムノグロブリン類のイムノアツセイ
CA2064972A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins
DE69232859T2 (de) 1991-09-13 2003-04-10 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
US5618533A (en) * 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
WO1993022343A1 (en) * 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
US6660276B1 (en) 1994-02-16 2003-12-09 The University Of Virginia Patent Foundation Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
NZ291153A (en) * 1994-07-25 1999-01-28 Boehringer Mannheim Gmbh Determination of a specific antibody using multiple antigens containing several epitope regions which react with the antibody
US5804371A (en) * 1994-07-25 1998-09-08 Boehringer Mannheim Gmbh Hapten-labelled peptides
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten

Also Published As

Publication number Publication date
EP0772774B1 (de) 2006-06-28
AU3220495A (en) 1996-02-22
CN1148578C (zh) 2004-05-05
WO1996003652A1 (de) 1996-02-08
AU688953B2 (en) 1998-03-19
US20050074750A1 (en) 2005-04-07
US6613530B1 (en) 2003-09-02
NO970292D0 (no) 1997-01-23
FI970301L (fi) 1997-03-24
ATE331952T1 (de) 2006-07-15
CN1157655A (zh) 1997-08-20
US7629295B2 (en) 2009-12-08
NZ291153A (en) 1999-01-28
CA2195753A1 (en) 1996-02-08
DE59511054D1 (de) 2006-08-10
EP0772774A1 (de) 1997-05-14
JP3556228B2 (ja) 2004-08-18
FI970301A0 (fi) 1997-01-24
JPH10504539A (ja) 1998-05-06
CA2195753C (en) 2008-12-16
ES2268694T3 (es) 2007-03-16
US20100136519A1 (en) 2010-06-03
FI970301A7 (fi) 1997-03-24

Similar Documents

Publication Publication Date Title
NO970292D0 (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
EP0315364A3 (en) Simultaneous immunoassay for the determination of antigens and antibodies
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
DK165785D0 (da) Immunometrisk bestemmelse rettet mod flere steder
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
EP0310132A3 (en) Immunoassay utilizing igg capture antibody and multiple monoclonal antibody detection system
DE59511101D1 (de) Metallchelat-markierte peptide
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
EP0902286A3 (en) Immunoassay utilizing two incubations with labelled antigen
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
ES2061324T3 (es) Complejo aglutinante como reactivo de identificacion de grupo sanguineo.
AU636964B2 (en) Immunological detection of metolachlor
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
NO903820D0 (no) Fremgangsmaate for paavisning av analytter.
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application